A citation-based method for searching scientific literature

Jonathan Ac Sterne, Miguel A Hernán, Barnaby C Reeves, Jelena Savović, Nancy D Berkman, Meera Viswanathan, David Henry, Douglas G Altman, Mohammed T Ansari, Isabelle Boutron, James R Carpenter, An-Wen Chan, Rachel Churchill, Jonathan J Deeks, Asbjørn Hróbjartsson, Jamie Kirkham, Peter Jüni, Yoon K Loke, Theresa D Pigott, Craig R Ramsay, Deborah Regidor, Hannah R Rothstein, Lakhbir Sandhu, Pasqualina L Santaguida, Holger J Schünemann, Beverly Shea, Ian Shrier, Peter Tugwell, Lucy Turner, Jeffrey C Valentine, Hugh Waddington, Elizabeth Waters, George A Wells, Penny F Whiting, Julian Pt Higgins. BMJ 2016
Times Cited: 3405







List of co-cited articles
85 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


RoB 2: a revised tool for assessing risk of bias in randomised trials.
Jonathan A C Sterne, Jelena Savović, Matthew J Page, Roy G Elbers, Natalie S Blencowe, Isabelle Boutron, Christopher J Cates, Hung-Yuan Cheng, Mark S Corbett, Sandra M Eldridge,[...]. BMJ 2019
25

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
19

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Julian P T Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savovic, Kenneth F Schulz, Laura Weeks, Jonathan A C Sterne. BMJ 2011
12

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
11

Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
9

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.
Gordon H Guyatt, Andrew D Oxman, Gunn E Vist, Regina Kunz, Yngve Falck-Ytter, Pablo Alonso-Coello, Holger J Schünemann. BMJ 2008
9

Quantifying heterogeneity in a meta-analysis.
Julian P T Higgins, Simon G Thompson. Stat Med 2002
9

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. BMJ 2009
8

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
David Moher, Larissa Shamseer, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. Syst Rev 2015
8

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Ann Intern Med 2009
7

Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
7

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
Beverley J Shea, Barnaby C Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, Vivian Welch, Elizabeth Kristjansson,[...]. BMJ 2017
6

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Int J Surg 2010
6

Meta-analysis in clinical trials.
R DerSimonian, N Laird. Control Clin Trials 1986
6

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. J Clin Epidemiol 2009
6

Estimating the mean and variance from the median, range, and the size of a sample.
Stela Pudar Hozo, Benjamin Djulbegovic, Iztok Hozo. BMC Med Res Methodol 2005
5

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
D F Stroup, J A Berlin, S C Morton, I Olkin, G D Williamson, D Rennie, D Moher, B J Becker, T A Sipe, S B Thacker. JAMA 2000
5

GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence.
Holger J Schünemann, Carlos Cuello, Elie A Akl, Reem A Mustafa, Jörg J Meerpohl, Kris Thayer, Rebecca L Morgan, Gerald Gartlehner, Regina Kunz, S Vittal Katikireddi,[...]. J Clin Epidemiol 2019
162
5

Assessing the quality of reports of randomized clinical trials: is blinding necessary?
A R Jadad, R A Moore, D Carroll, C Jenkinson, D J Reynolds, D J Gavaghan, H J McQuay. Control Clin Trials 1996
4

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. J Clin Epidemiol 2009
4

Rayyan-a web and mobile app for systematic reviews.
Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz, Ahmed Elmagarmid. Syst Rev 2016
4


GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.
Gordon Guyatt, Andrew D Oxman, Elie A Akl, Regina Kunz, Gunn Vist, Jan Brozek, Susan Norris, Yngve Falck-Ytter, Paul Glasziou, Hans DeBeer,[...]. J Clin Epidemiol 2011
4

Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline.
Mhairi Campbell, Joanne E McKenzie, Amanda Sowden, Srinivasa Vittal Katikireddi, Sue E Brennan, Simon Ellis, Jamie Hartmann-Boyce, Rebecca Ryan, Sasha Shepperd, James Thomas,[...]. BMJ 2020
284
4

The GRADE Working Group clarifies the construct of certainty of evidence.
Monica Hultcrantz, David Rind, Elie A Akl, Shaun Treweek, Reem A Mustafa, Alfonso Iorio, Brian S Alper, Joerg J Meerpohl, M Hassan Murad, Mohammed T Ansari,[...]. J Clin Epidemiol 2017
170
4

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
Larissa Shamseer, David Moher, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. BMJ 2015
4

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. Ann Intern Med 2009
3

The nuts and bolts of PROSPERO: an international prospective register of systematic reviews.
Alison Booth, Mike Clarke, Gordon Dooley, Davina Ghersi, David Moher, Mark Petticrew, Lesley Stewart. Syst Rev 2012
481
3

Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.
Lesley A Stewart, Mike Clarke, Maroeska Rovers, Richard D Riley, Mark Simmonds, Gavin Stewart, Jayne F Tierney. JAMA 2015
792
3


Evaluation of the risk of bias in non-randomized studies of interventions (ROBINS-I) and the 'target experiment' concept in studies of exposures: Rationale and preliminary instrument development.
Rebecca L Morgan, Kristina A Thayer, Nancy Santesso, Alison C Holloway, Robyn Blain, Sorina E Eftim, Alexandra E Goldstone, Pam Ross, Gordon Guyatt, Holger J Schünemann. Environ Int 2018
33
9

SYRCLE's risk of bias tool for animal studies.
Carlijn R Hooijmans, Maroeska M Rovers, Rob B M de Vries, Marlies Leenaars, Merel Ritskes-Hoitinga, Miranda W Langendam. BMC Med Res Methodol 2014
872
3

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei, Manuel Castella, Hans-Christoph Diener, Hein Heidbuchel, Jeroen Hendriks,[...]. Eur Heart J 2016
3


GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias).
Gordon H Guyatt, Andrew D Oxman, Gunn Vist, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, Victor Montori, Elie A Akl, Ben Djulbegovic, Yngve Falck-Ytter,[...]. J Clin Epidemiol 2011
3

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. PLoS Med 2009
3

Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range.
Dehui Luo, Xiang Wan, Jiming Liu, Tiejun Tong. Stat Methods Med Res 2018
455
2



Evaluating non-randomised intervention studies.
J J Deeks, J Dinnes, R D'Amico, A J Sowden, C Sakarovitch, F Song, M Petticrew, D G Altman. Health Technol Assess 2003
2

Do psychological variables affect early surgical recovery?
Michael N Mavros, Stavros Athanasiou, Ioannis D Gkegkes, Konstantinos A Polyzos, George Peppas, Matthew E Falagas. PLoS One 2011
98
2


Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.
Clive Kearon, Elie A Akl, Joseph Ornelas, Allen Blaivas, David Jimenez, Henri Bounameaux, Menno Huisman, Christopher S King, Timothy A Morris, Namita Sood,[...]. Chest 2016
2


Basics of meta-analysis: I2 is not an absolute measure of heterogeneity.
Michael Borenstein, Julian P T Higgins, Larry V Hedges, Hannah R Rothstein. Res Synth Methods 2017
432
2

Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study.
Matthew J Page, Larissa Shamseer, Douglas G Altman, Jennifer Tetzlaff, Margaret Sampson, Andrea C Tricco, Ferrán Catalá-López, Lun Li, Emma K Reid, Rafael Sarkis-Onofre,[...]. PLoS Med 2016
291
2

A re-evaluation of random-effects meta-analysis.
Julian P T Higgins, Simon G Thompson, David J Spiegelhalter. J R Stat Soc Ser A Stat Soc 2009
2

A risk of bias instrument for non-randomized studies of exposures: A users' guide to its application in the context of GRADE.
Rebecca L Morgan, Kristina A Thayer, Nancy Santesso, Alison C Holloway, Robyn Blain, Sorina E Eftim, Alexandra E Goldstone, Pam Ross, Mohammed Ansari, Elie A Akl,[...]. Environ Int 2019
49
4

GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology.
Gordon H Guyatt, Andrew D Oxman, Holger J Schünemann, Peter Tugwell, Andre Knottnerus. J Clin Epidemiol 2011
2

Grading quality of evidence and strength of recommendations.
David Atkins, Dana Best, Peter A Briss, Martin Eccles, Yngve Falck-Ytter, Signe Flottorp, Gordon H Guyatt, Robin T Harbour, Margaret C Haugh, David Henry,[...]. BMJ 2004
2


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.